Karnataka: Shivamogga Doctor Dies; Govt Says Not Linked To Vaccine

BENGALURU : A 58-year-old doctor from Shivamogga died on Wednesday, two days after he was given Covishield vaccine. The Union health ministry’s report on Adverse Effects Following Immunisation said the death was due to cardiac problems. District health officer Rajesh Suragihalli said the death of Dr Jayaprakash TA, who was with Subbaiah medical college hospital, is not linked to the vaccination drive.

He developed severe chest pain in the early hours of Wednesday and was admitted to a private hospital where he died hours later, said Dr SM Katti, principal of the medical college. District health officer Dr Rajesh Suragihalli told TOI: “He died due to cardiac problems. He had been suffering from heart-related issues for some time now. His death is not related to the vaccine drive, which is also confirmed by the Union health ministry. After taking vaccination, he had shared his pictures on social media and requested frontline warriors to come forward.”

Jayaprakash’s wife, a gynaecologist who works in Shivamogga, and two daughters are away in the US. Katti said the doctor suffered a cardiac arrest and the death is not linked to the vaccine.

Pankaj Kumar Pandey, commissioner, health and family welfare department, said the doctor had conducted classes after his vaccination and was doing well after taking the jab. “It is learned that he was highly diabetic and had undergone bypass surgery earlier. The reports say that he has died due to cardiac arrest,” he said.

Related Posts

  • Pharma
  • June 25, 2025
  • 104 views
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

  • Pharma
  • June 25, 2025
  • 111 views
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India